J Lachaine

Summary

Country: Canada

Publications

  1. doi request reprint Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Station Centre Ville, PO Box 6128, H3C 3 J7 Montreal, Quebec, Canada
    BMC Psychiatry 14:16. 2014
  2. pmc Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    BMC Gastroenterol 13:23. 2013
  3. doi request reprint Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Postgrad Med 124:139-48. 2012
  4. pmc Study protocol of the YOU CALL--WE CALL TRIAL: impact of a multimodal support intervention after a "mild" stroke
    Annie Rochette
    Montreal University, Montreal, Quebec, Canada
    BMC Neurol 10:3. 2010
  5. ncbi request reprint Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease
    Jean Lachaine
    University of Montreal, Quebec
    Can J Psychiatry 56:596-604. 2011
  6. pmc Use, tolerability and compliance of spironolactone in the treatment of heart failure
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    BMC Clin Pharmacol 11:4. 2011
  7. doi request reprint Clinical and economic characteristics of patients with fibromyalgia syndrome
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Clin J Pain 26:284-90. 2010
  8. ncbi request reprint Cost-efficacy analysis of ondansetron regimens for control of emesis induced by noncisplatin, moderately emetogenic chemotherapy
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, P O Box 6128, Succursale Centre Ville, Montreal, Quebec, Canada
    Am J Health Syst Pharm 59:1837-46. 2002
  9. pmc Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec
    Can J Cardiol 24:269-73. 2008
  10. ncbi request reprint Defining monetary values for quality of life improvements: an exploratory study
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Pharmacoeconomics 21:865-74. 2003

Detail Information

Publications23

  1. doi request reprint Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Station Centre Ville, PO Box 6128, H3C 3 J7 Montreal, Quebec, Canada
    BMC Psychiatry 14:16. 2014
    ..In addition, it is associated with a favourable metabolic profile and minimal weight gain potential. This study aimed to assess the economic impact of asenapine compared to olanzapine in the treatment of BPD in Canada...
  2. pmc Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    BMC Gastroenterol 13:23. 2013
    ..The objective of this study was to assess adherence and persistence to mesalamine treatments and their potential determinants in mild to moderate UC patients in a real-life setting in Quebec, Canada...
  3. doi request reprint Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Postgrad Med 124:139-48. 2012
    ..To understand attention-deficit/hyperactivity disorder (ADHD) treatment patterns and estimate adherence and persistence in Quebec, Canada...
  4. pmc Study protocol of the YOU CALL--WE CALL TRIAL: impact of a multimodal support intervention after a "mild" stroke
    Annie Rochette
    Montreal University, Montreal, Quebec, Canada
    BMC Neurol 10:3. 2010
    ....
  5. ncbi request reprint Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease
    Jean Lachaine
    University of Montreal, Quebec
    Can J Psychiatry 56:596-604. 2011
    ..Our study aimed to evaluate the economic impact of the concomitant use of memantine and a ChEI, compared with a ChEI alone, in a Canadian population of patients with AD...
  6. pmc Use, tolerability and compliance of spironolactone in the treatment of heart failure
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    BMC Clin Pharmacol 11:4. 2011
    ..The aim of this study was to estimate use of spironolactone by patients with HF, incidence of key adverse events, and patient compliance...
  7. doi request reprint Clinical and economic characteristics of patients with fibromyalgia syndrome
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Clin J Pain 26:284-90. 2010
    ..The objectives of this study were to estimate prevalence of comorbidities, healthcare resources utilization, and costs associated with FMS...
  8. ncbi request reprint Cost-efficacy analysis of ondansetron regimens for control of emesis induced by noncisplatin, moderately emetogenic chemotherapy
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, P O Box 6128, Succursale Centre Ville, Montreal, Quebec, Canada
    Am J Health Syst Pharm 59:1837-46. 2002
    ..The analysis supported the concomitant use of a corticosteroid, twice-daily administration of ondansetron, and limitation of ondansetron administration to a period not exceeding four days...
  9. pmc Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec
    Can J Cardiol 24:269-73. 2008
    ..Given the need for long-term use of antihypertensive agents, treatment compliance should also be taken into consideration in the selection process...
  10. ncbi request reprint Defining monetary values for quality of life improvements: an exploratory study
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Pharmacoeconomics 21:865-74. 2003
    ..Objective: To explore the feasibility of assessing the monetary value of an intervention by translating the improvement in QOL it produces into willingness to pay (WTP) amounts...
  11. ncbi request reprint Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Am Heart J 152:164-9. 2006
    ..There is a concern that poor compliance to cholesterol lowering agents (CLA) may compromise their potential benefits. The objective of this study was to estimate compliance to CLAs, in the context of clinical practice in Quebec...
  12. ncbi request reprint Therapeutic options for the prevention and treatment of postoperative nausea and vomiting: a pharmacoeconomic review
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Pharmacoeconomics 24:955-70. 2006
    ..Many questions remain unanswered about the cost effectiveness of existing antiemetics and their regimens, and little is known about the impact of new agents, such as the neurokinin-1 receptor antagonists, in the control of PONV...
  13. pmc Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database
    J Lachaine
    University of Montreal, Montreal, Quebec, Canada
    Pain Res Manag 12:31-7. 2007
    ..In most cases, PNDs involve the peripheral nerves. Treatment of PNDs is likely to use large health care resources. However, little is known about the economic burden of PNDs in Canada...
  14. doi request reprint Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?
    Mathieu Beaulieu
    Faculty of Pharmacy, Universite de Montreal, Hopital du Sacre Coeur de Montreal, Quebec, Canada
    J Crit Care 23:513-8. 2008
    ..The aim of this study was to determine whether the use of gastric acid-suppressive agents increases the risk of nosocomial pneumonia (NP) in a medical intensive care unit population...
  15. doi request reprint Systematic review of pharmacoeconomic studies of pharmacogenomic tests
    Mathieu Beaulieu
    Faculte de Pharmacie, Universite de Montreal, PO Box 6128, Succ Centre Ville, Montreal, Quebec, H3C 3J7, Canada
    Pharmacogenomics 11:1573-90. 2010
    ..In order to fully assess all aspects of pharmacogenomic testing, future pharmacoeconomic assessments should include every specific component that has an impact on the incremental cost-effectiveness ratio...
  16. doi request reprint Economic impact of the advent of posterior lamellar keratoplasty in Montreal, Quebec
    Catherine Beauchemin
    Faculty of Pharmacy, University of Montreal, Montreal, Que
    Can J Ophthalmol 45:243-51. 2010
    ....
  17. ncbi request reprint A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Clin Ther 29:519-28. 2007
    ..Statins differ in their LDL-C-lowering effects and acquisition costs. Atorvastatin and simvastatin are the 2 most commonly used statins in Canada...
  18. doi request reprint Cost of corneal transplantation for the Quebec health care system
    Jean Pascal F Roussy
    Faculty of Pharmacy, University of Montreal, Montreal, Que
    Can J Ophthalmol 44:36-41. 2009
    ..The purpose of this study was to estimate resource use and costs associated with corneal transplantation according to a public third-party perspective...
  19. ncbi request reprint Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women
    Vakaramoko Diaby
    Faculty of Pharmacy, University of Montreal, Centre Ville, Montreal, QC H3C 3J7, Canada
    Maturitas 58:138-49. 2007
    ..It has been used in Europe, in the same indication as CCHRT, for approximately 20 years but is not yet available in Canada...
  20. ncbi request reprint Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit
    Mathieu Beaulieu
    Faculty of Pharmacy, Universite de Montreal, Montreal, QC, H3C 3J7, Canada
    Infect Control Hosp Epidemiol 28:1305-7. 2007
    ..Our findings suggest that efforts to determine risk factors for CDAD should focus on other areas, such as older age and antibiotic use...
  21. doi request reprint Prostaglandin analogues for ophthalmic use: a cost-effectiveness analysis
    Jean Lachaine
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Quebec, Canada
    Can J Ophthalmol 43:33-41. 2008
    ..An important policy decision is whether to support continued open listing of these agents or to restrict them to limited use status...
  22. doi request reprint Determinants of adherence to glaucoma medical therapy in a long-term patient population
    Fawzia Djafari
    Department of Ophthalmology, University of Montreal, Quebec, Canada
    J Glaucoma 18:238-43. 2009
    ..Estimate patient adherence to glaucoma medications and identify potential determinants of nonadherence...
  23. ncbi request reprint Interprofessional health care teams: attitudes and environmental factors associated with participation by community pharmacists
    Roy T Dobson
    College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    J Interprof Care 20:119-32. 2006
    ....